MWNA
NTUS

Marshall Wace North America’s Natus Medical Inc NTUS Stock Holding History

Marshall Wace North America’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-98,810
Closed -$2.16M – 1569
2020
Q2 		$2.16M Buy
98,810
+82,858
+519% +$1.9M 0.01% 578
2020
Q1 		$370K Buy
+15,952
New +$464K ﹤0.01% 814
2019
Q4 		– Sell
-5,660
Closed -$180K – 1708
2019
Q3 		$180K Buy
+5,660
New +$165K ﹤0.01% 977
2017
Q4 		– Sell
-30,913
Closed -$1.18M – 1688
2017
Q3 		$1.18M Sell
30,913
-126,696
-80% -$4.47M 0.01% 913
2017
Q2 		$5.83M Buy
+157,609
New +$5.69M 0.04% 459

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace North America's NTUS Position: Q3 2020 in Review

Marshall Wace North America sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 98,810 shares — an estimated $2.16M sold.

Marshall Wace North America first reported a position in NTUS in Q2 2017 and held it in 5 quarters. The position peaked at $5.83M in Q2 2017. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • Marshall Wace North America reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace North America sold 98,810 Natus Medical Inc shares in Q3 2020, an estimated $2.16M.
  • Marshall Wace North America first reported a position in Natus Medical Inc in Q2 2017 and held it in 5 quarters.
  • Marshall Wace North America's Natus Medical Inc position peaked at $5.83M in Q2 2017.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.